大国角力的新领域:基因数据_BEC初级作文

大国角力的新领域:基因数据

一些观察人士认为，美国政府就中国在基因组领域投资的影响提出疑问是正确之举。“我从未看到过FBI突然冒出来这么做，”美国国会批准创建的顾问组织——美中经济与安全评估委员会(US-China Economic and Security Review Commission)成员迈克尔?韦赛尔(Michael Wessel)表示，“这个关键领域需要更多关注……这是真正的威胁。”

Others worry that it would be damaging for the US to put up excessive barriers to Chinese biomedical investment. Dan Rosen, founding partner at the Rhodium Group in New York, points out that China has invested more than $3.2bn in the US biotech and pharmaceuticals sector over the past five years — cash that often brings with it talented Chinese scientists. In some disciplines, such as large-scale, low-cost gene sequencing, China leads the US. If Chinese companies become less welcome in the US, he says, they will go elsewhere.

另有一些人担心，美国对中国生物医学投资设置过多障碍将是破坏性的。纽约荣鼎咨询(Rhodium Group)创始合伙人丹?罗森(Dan Rosen)指出，过去5年，中国在美国生物技术和制药领域投资逾32亿美元，随之而来的往往是优秀的中国科学家。在一些领域，例如大规模低成本基因测序领域，中国领先于美国。他表示，如果中国公司在美国变得不那么受欢迎，他们会到别处去。

“I don’t think drawing a line around biotech and calling the entire industry a critical sector is going to do the trick,” said Mr Rosen. “We’re going to have to maintain the ability to look at investments case by case.”